Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)

Clinical trial NCT02421926 · WITHDRAWN

Trial details

NCT number: NCT02421926
Sponsor: Asan Medical Center
Status: WITHDRAWN
Study type: OBSERVATIONAL

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Start date: 2014-10-01
Primary completion: 2023-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.